[RANHILL] QoQ Annualized Quarter Result on 31-Mar-2020 [#1]

Stock
[RANHILL] RANHILL UTILITIES BERHAD
Announcement Date
20-May-2020
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2020
Quarter
31-Mar-2020 [#1]
Profit Trend
QoQ- -10.73%
YoY- -14.87%
Quarter Report
Latest QR
Upcoming QR
RANHILL's Result
RANHILL's Financial Summary
View:
Show?
Annualized Quarter Result
31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 CAGR
Revenue 1,478,409 1,496,849 1,474,318 1,473,124 1,629,943 1,650,804 1,658,086 -7.32%
PBT 92,815 145,517 141,716 165,120 236,383 196,970 199,714 -39.86%
Tax -30,368 -49,612 -45,506 -55,672 -105,125 -72,728 -71,332 -43.26%
NP 62,447 95,905 96,210 109,448 131,258 124,242 128,382 -38.01%
-
NP to SH 36,492 61,965 62,756 72,760 81,505 76,890 80,076 -40.63%
-
Tax Rate 32.72% 34.09% 32.11% 33.72% 44.47% 36.92% 35.72% -
Total Cost 1,415,962 1,400,944 1,378,108 1,363,676 1,498,685 1,526,561 1,529,704 -4.99%
-
Net Worth 459,826 584,442 586,558 599,084 586,286 575,626 575,626 -13.84%
Dividend
31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 CAGR
Div 42,239 41,796 42,658 85,583 53,298 42,639 42,639 -0.62%
Div Payout % 115.75% 67.45% 67.98% 117.62% 65.39% 55.45% 53.25% -
Equity
31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 CAGR
Net Worth 459,826 584,442 586,558 599,084 586,286 575,626 575,626 -13.84%
NOSH 1,072,936 1,072,936 1,072,936 1,072,936 1,065,975 1,065,975 1,065,975 0.43%
Ratio Analysis
31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 CAGR
NP Margin 4.22% 6.41% 6.53% 7.43% 8.05% 7.53% 7.74% -
ROE 7.94% 10.60% 10.70% 12.15% 13.90% 13.36% 13.91% -
Per Share
31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 CAGR
RPS 138.25 140.86 138.24 137.70 152.91 154.86 155.55 -7.52%
EPS 3.42 5.81 5.88 6.80 7.65 7.21 7.52 -40.71%
DPS 3.95 3.93 4.00 8.00 5.00 4.00 4.00 -0.83%
NAPS 0.43 0.55 0.55 0.56 0.55 0.54 0.54 -14.02%
Adjusted Per Share Value based on latest NOSH - 1,072,936
31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 CAGR
RPS 114.01 115.43 113.69 113.60 125.69 127.30 127.86 -7.32%
EPS 2.81 4.78 4.84 5.61 6.29 5.93 6.17 -40.66%
DPS 3.26 3.22 3.29 6.60 4.11 3.29 3.29 -0.60%
NAPS 0.3546 0.4507 0.4523 0.462 0.4521 0.4439 0.4439 -13.84%
Price Multiplier on Financial Quarter End Date
31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 CAGR
Date 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 28/06/19 -
Price 0.905 0.89 0.93 0.90 1.07 1.20 1.25 -
P/RPS 0.65 0.63 0.67 0.65 0.70 0.77 0.80 -12.87%
P/EPS 26.52 15.26 15.80 13.23 13.99 16.64 16.64 36.24%
EY 3.77 6.55 6.33 7.56 7.15 6.01 6.01 -26.61%
DY 4.36 4.42 4.30 8.89 4.67 3.33 3.20 22.78%
P/NAPS 2.10 1.62 1.69 1.61 1.95 2.22 2.31 -6.12%
Price Multiplier on Announcement Date
31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 CAGR
Date 29/03/21 26/11/20 26/08/20 20/05/20 27/02/20 07/11/19 14/08/19 -
Price 0.835 0.825 0.88 1.02 0.96 1.25 1.33 -
P/RPS 0.60 0.59 0.64 0.74 0.63 0.81 0.86 -21.25%
P/EPS 24.47 14.15 14.95 15.00 12.56 17.33 17.71 23.93%
EY 4.09 7.07 6.69 6.67 7.96 5.77 5.65 -19.29%
DY 4.73 4.77 4.55 7.84 5.21 3.20 3.01 34.97%
P/NAPS 1.94 1.50 1.60 1.82 1.75 2.31 2.46 -14.58%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment